Rohinitib 是一种有效的以及特异性的 eIF4A 抑制剂。Rohinitib 诱导急性髓系白血病 (AML) 细胞系的凋亡,并减轻在 AML 异种移植模型小鼠的白血病负担。Rohinitib 可用于 AML 的研究。
生物活性
Rohinitib is a potent and specific eIF4A inhibitor. Rohinitib induces cell apoptosis of acute myeloid leukemia (AML) cell lines and reduces the leukemia burden of AML xenograft model. Rohinitib can be used for the research of AML.
性状
Solid
体外研究(In Vitro)
Rohinitib (6.25-50 nM; 72 h) induces cell apoptosis of AML cell lines and FLT3 -ITD-positive AML cell lines.Primary AML cells is more sensitive to Rohinitib (25 nM; 72 h) than normal bone marrow (BM) and FLT3 -ITD-positive cells is more sensitive to Rohinitib than FLT3 wild-type AML cells. has not independently confirmed the accuracy of these methods. They are for reference only.Apoptosis Analysis
体内研究(In Vivo)
Rohinitib (0.75 and 1.0 mg/kg; s.c. once daily for 5 consecutive days until mice get moribund) shows anti-AML effects in vivo. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Female N
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Nishida Y, et alJ. Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML. Leukemia. 2021 Sep;35(9):2469-2481.
溶解度数据
In Vitro: DMSO : 200 mg/mL (383.46 mM; Need ultrasonic)配制储备液